Biocryst Pharmaceuticals (BCRX) Long-Term Investments (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted Long-Term Investments of $20.57 million for Q1 2026, up 0.1% from $20.55 million a year earlier but down 66.4% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Long-Term Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Biocryst Pharmaceuticals' Long-Term Investments came in at $61.16 million, up 201.0% from FY2024.
- Annual Long-Term Investments shows a four-year compound annual growth rate of 73.0% (FY2021 to FY2025).
- In prior years, Biocryst Pharmaceuticals' Long-Term Investments was $20.32 million in FY2024, $18.08 million in FY2022 (+164.7%) and $6.83 million in FY2021.
- Quarterly Long-Term Investments has run from a low of $3.43 million in Q1 2023 to a high of $64.32 million in Q2 2024 over five years.
- On a year-over-year basis, Long-Term Investments has increased in each of the last three quarters, with growth averaging 55.2% over the last four quarters.
- According to Business Quant data, Long-Term Investments for the three prior quarters was $61.16 million (Q4 2025), $39.67 million (Q3 2025) and $10.1 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Biocryst Pharmaceuticals | 2.13 Bn | 1.05 Bn | 214.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 20.57 Mn |
| Dec 31, 2025 | 61.16 Mn |
| Sep 30, 2025 | 39.67 Mn |
| Jun 30, 2025 | 10.10 Mn |
| Mar 31, 2025 | 20.55 Mn |
| Dec 31, 2024 | 20.32 Mn |
| Sep 30, 2024 | 19.43 Mn |
| Jun 30, 2024 | 64.32 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 3.43 Mn |
| Dec 31, 2022 | 18.08 Mn |
| Sep 30, 2022 | 34.33 Mn |
| Dec 31, 2021 | 6.83 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2019 | 741,000.00 |
| Mar 31, 2019 | 11.66 Mn |
| Dec 31, 2018 | 22.38 Mn |
| Sep 30, 2018 | 29.16 Mn |
| Jun 30, 2018 | 33.74 Mn |
| Mar 31, 2018 | 41.60 Mn |
API Access
Biocryst Pharmaceuticals Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();